The prognosis for patients with glioblastoma (GB) remains grim. Concurrent temozolomide (TMZ) radiation-the cornerstone of glioma control-extends the overall median survival of GB patients by only a few months over radiotherapy alone. While these survival gains could be partly attributed to radiosensitization. this benefit is greatly minimized in tumors expressing O6-methylguanine DNA... https://jeepworldes.shop/product-category/body-armor-protection/